Skip to main content

Advertisement

Table 3 Late adverse events (n = 20)

From: Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes

Events Distribution and%
Small bowel obstruction * 3 (15%)
Sigmoid perforation* 1 (5%)
Chronic radiation enteritis and proctitis CTC 1 1 (5%)
Radiation pneumonitis CTC 1 1 (5%)
Vaginal dryness and teleangiectasia 3 (15%)
Dyspareunia 1 (5%)
Urinary urgency CTC 1 1 (5%)
Chronic fatigue 3 (15%)
Chronic neuropathy CTC 2 2 (10%)
Chronic leg oedema 1 (5%)
Tight cellulitis 1 (5%)
Infected lymphocele 1 (5%)
Renal failure** 1 (5%)
Erosive gastritis 1 (5%)
  1. * all in the context of recurrent intraperitoneal recurrent disease.
  2. **Attributed to severe type II diabetic nephropathy, did not receive chemo because of severe diabetes.
  3. Some patients have >1 adverse event.